STATE STREET CORP - BIOMARIN PHARMACEUTICAL INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2020$12,912,000
+14.2%
9,800,000
-7.5%
0.00%0.0%
Q1 2020$11,304,000
-15.5%
10,600,000
-13.8%
0.00%0.0%
Q4 2019$13,383,000
+7.4%
12,300,000
+2.5%
0.00%0.0%
Q3 2019$12,462,000
-3.7%
12,000,000
+4.3%
0.00%0.0%
Q2 2019$12,940,000
+13.8%
11,500,000
+15.6%
0.00%0.0%
Q1 2019$11,373,000
-16.7%
9,950,000
-18.8%
0.00%0.0%
Q4 2018$13,645,000
-14.6%
12,250,000
-7.5%
0.00%0.0%
Q3 2018$15,975,000
+3.3%
13,250,000
+1.5%
0.00%0.0%
Q2 2018$15,466,000
+20.4%
13,050,000
+13.0%
0.00%0.0%
Q1 2018$12,850,000
-6.4%
11,550,0000.0%0.00%0.0%
Q4 2017$13,730,000
-2.6%
11,550,000
-0.9%
0.00%0.0%
Q3 2017$14,099,00011,650,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 6,195,000$9,377,0002.84%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,000,000$10,750,0001.09%
Man Investments (CH) AG 1,100,000$1,482,0000.73%
ADVENT CAPITAL MANAGEMENT /DE/ 22,554,000$30,444,0000.47%
SSI INVESTMENT MANAGEMENT LLC 3,124,000$4,202,0000.45%
ARROWGRASS CAPITAL PARTNERS (US) LP 20,000$22,373,0000.42%
Calamos Advisors LLC 35,219,000$47,628,0000.33%
LINDEN ADVISORS LP 2,500,000$3,370,0000.23%
Calamos Wealth Management LLC 513,000$694,0000.17%
LOOMIS SAYLES & CO L P 477,810$50,323,0000.15%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders